Pages that link to "Q53855595"
Jump to navigation
Jump to search
The following pages link to Selective targeted delivery of TNFalpha to tumor blood vessels. (Q53855595):
Displaying 50 items.
- A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties (Q24320137) (← links)
- Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes (Q26991991) (← links)
- The development of immunoconjugates for targeted cancer therapy (Q27021990) (← links)
- Optimal MHC-II-restricted tumor antigen presentation to CD4 T helper cells: the key issue for development of anti-tumor vaccines (Q27030560) (← links)
- Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site (Q28066935) (← links)
- Novel ubiquitin-derived high affinity binding proteins with tumor targeting properties (Q30317537) (← links)
- Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed. (Q33325343) (← links)
- Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8. (Q33531787) (← links)
- Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12. (Q33605532) (← links)
- Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma (Q33607479) (← links)
- Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma (Q34253705) (← links)
- Heptameric targeting ligands against EGFR and HER2 with high stability and avidity (Q34389242) (← links)
- A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels (Q34746019) (← links)
- Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies (Q34756337) (← links)
- Use of the uteroglobin platform for the expression of a bivalent antibody against oncofetal fibronectin in Escherichia coli (Q35075470) (← links)
- Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety (Q35163167) (← links)
- Development trends for generation of single-chain antibody fragments (Q35216785) (← links)
- TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage (Q35642213) (← links)
- Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis (Q35769069) (← links)
- Molecular targeting of angiogenesis for imaging and therapy (Q35858490) (← links)
- Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy. (Q35974293) (← links)
- The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth. (Q36123270) (← links)
- Tumour vascular targeting (Q36146905) (← links)
- ED-B fibronectin as a target for antibody-based cancer treatments (Q36158702) (← links)
- Antibody-based antiangiogenic cancer therapy. (Q36318555) (← links)
- Fibronectin as target for tumor therapy (Q36354769) (← links)
- Antibody targeted drugs as cancer therapeutics (Q36373103) (← links)
- Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site (Q36411863) (← links)
- Gene therapy targeting to tumor endothelium (Q36649681) (← links)
- Ligand-based vascular targeting of disease (Q36677212) (← links)
- New approaches in metastatic melanoma: biological and molecular targeted therapies (Q36817127) (← links)
- The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity (Q37185752) (← links)
- Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha (Q37220415) (← links)
- Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine (Q37236248) (← links)
- Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer (Q37294534) (← links)
- Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours (Q37330712) (← links)
- TNF-alpha and its inhibitors in cancer (Q37412511) (← links)
- Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins (Q37446755) (← links)
- Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis (Q37453905) (← links)
- Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions (Q37485709) (← links)
- Fibronectin extra domain A (EDA) sustains CD133( )/CD44( ) subpopulation of colorectal cancer cells (Q37566991) (← links)
- Stromal Modulators of TGF-β in Cancer (Q37628179) (← links)
- Jekyll and Hyde: the role of the microenvironment on the progression of cancer (Q37815128) (← links)
- Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy. (Q38066025) (← links)
- Immunocytokines: a review of molecules in clinical development for cancer therapy (Q38132742) (← links)
- Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4 T Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor Microenvironment Toward an Anti-Tumor State (Q38193821) (← links)
- Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs (Q38364462) (← links)
- Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8 T-cell Recognition of a Retroviral Antigen (Q38704265) (← links)
- The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells. (Q38716421) (← links)
- Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy (Q38988662) (← links)